Training future leaders in pediatric drug therapy
Official title: Clinical Pharmacology K12 Training Program
Funded at Cincinnati Childrens Hosp Med Ctr · NIH-10892271 · Data updated 2026-11-12
This program is designed to help new doctors learn how to safely use and study medications for children, making sure that new treatments are tested properly for young patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $297,000 |
| NIH project number | 5K12HD113190-02 |
| Project ID | NIH-10892271 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 0-11 years who may require new or improved drug therapies.
✕Less likely to help
Patients who are older than 11 years or those not requiring drug therapy may not benefit from this research.
What this research studies
This program focuses on training junior faculty in Pediatric Clinical Pharmacology, emphasizing the safe and effective use of drugs in children. Participants will learn about the design and conduct of drug studies specifically for pediatric populations, ensuring that new therapies are appropriately tested and translated for young patients. The program aims to support those with varying levels of experience, from those new to clinical pharmacology to those transitioning to independent research roles. By leveraging the resources and expertise at Cincinnati Children's Hospital, the program fosters collaboration and hands-on learning.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective drug therapies for children.
How similar studies have gone: Other training programs in pediatric pharmacology have shown success in improving drug safety and efficacy for children, indicating a promising approach.
Where this research is happening
-
Cincinnati Childrens Hosp Med Ctr
Cincinnati, United States Active
Researchers
- Principal investigator: Tang Girdwood, Sonya C — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Tang Girdwood, Sonya C
Related research
Other NIH-funded projects on the same topics.
-
Accelerating Rheumatic Heart Disease Prevention in Uganda
A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.
-
Enhanced surveillance network to track childhood vaccines and viral infections in kids
A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.
-
Advancing CNS drug delivery through epigenetic tweaks
A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.
-
Spina Bifida Registry for Better Clinic Care
A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.
-
Hydroxyurea to help children with sickle cell anemia in Africa
A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.
-
Hydroxyurea for Children with Sickle Cell in Africa
A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.